TCT-37 Impact of LVEF on Baseline Characteristics and Outcomes in TTVR Recipients
Recommended Citation
Abdelhai O, Kamalipour P, Frisoli T, Villablanca P, Alsaadi A, O'Neill W, Parikh S, Jabri A, Yap R, Patel R, Lee J, Ghoneem A, O'Neill B. TCT-37 Impact of LVEF on Baseline Characteristics and Outcomes in TTVR Recipients. J Am Coll Cardiol 2025; 86(17):B20-B21.
Document Type
Conference Proceeding
Publication Date
10-28-2025
Publication Title
J Am Coll Cardiol
Abstract
Background: Severely reduced left ventricular ejection fraction (LVEF <35%) may influence outcomes in transcatheter tricuspid valve replacement (TTVR), yet data in this population remain limited. Methods: We analyzed 167 patients undergoing TTVR at a single center, stratified by LVEF <35% vs. ≥35%. Baseline characteristics, device success, length of stay (LOS), and 30-day readmission were compared using appropriate statistical tests. Results: Thirteen patients (7.8%) had LVEF <35%. Device success was slightly lower in the reduced EF group (92.3% vs. 97.4%, p = 0.293). Median LOS was similar (8.0 vs. 7.0 days, p = 0.908). Thirty-day readmission was higher in the LVEF <35% group (15.4% vs. 7.1%, p = 0.288), though not significant. Baseline characteristics showed lower BMI (24.1 vs. 27.3, p = 0.045) and higher BNP (1562 vs. 408 pg/mL, p = 0.001) in the reduced EF group. Fewer were female (30.8% vs. 63.6%, p = 0.034). [Formula presented] Conclusion: TTVR in patients with LVEF <35% is feasible, with comparable procedural success and hospital stay. These patients present with distinct clinical profiles, including lower BMI and higher BNP. Further studies are warranted to evaluate long-term outcomes in this high-risk subgroup. Categories: STRUCTURAL: Valvular Disease and Intervention: Tricuspid
Volume
86
Issue
17
First Page
B20
Last Page
B21
